OXALIPLATIN (Pfizer Laboratories Div Pfizer Inc.)
Welcome to the PulseAid listing for the OXALIPLATIN drug offered from Pfizer Laboratories Div Pfizer Inc.. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc. |
| NON-PROPRIETARY NAME: | OXALIPLATIN |
| SUBSTANCE NAME: | OXALIPLATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-08-09 |
| END MARKETING DATE: | 0000-00-00 |
OXALIPLATIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | OXALIPLATIN from Pfizer Laboratories Div Pfizer Inc. |
| LABELER NAME: | Pfizer Laboratories Div Pfizer Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/10mL) |
| START MARKETING DATE: | 2012-08-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0069-0067_2d79aad4-1444-4d81-a7e2-f98d303cbbce |
| PRODUCT NDC: | 0069-0067 |
| APPLICATION NUMBER: | ANDA200979 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers:
